|
REST expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.387200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.058400E-03 |
| Normal-vs-Stage2 |
1.424110E-02 |
| Normal-vs-Stage3 |
1.220910E-04 |
| Normal-vs-Stage4 |
3.9141999999992E-05 |
| Stage1-vs-Stage2 |
9.344400E-01 |
| Stage1-vs-Stage3 |
1.900430E-01 |
| Stage1-vs-Stage4 |
6.447600E-02 |
| Stage2-vs-Stage3 |
3.993800E-01 |
| Stage2-vs-Stage4 |
2.157400E-01 |
| Stage3-vs-Stage4 |
5.810200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.791400E-04 |
| Normal-vs-AfricanAmerican |
1.802760E-01 |
| Normal-vs-Asian |
1.616440E-03 |
| Caucasian-vs-AfricanAmerican |
3.064800E-01 |
| Caucasian-vs-Asian |
6.658000E-01 |
| AfricanAmerican-vs-Asian |
2.314200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.97210000002701E-06 |
| Normal-vs-Female |
6.380900E-04 |
| Male-vs-Female |
5.140100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.144200E-03 |
| Normal-vs-Age(41-60Yrs) |
3.042200E-04 |
| Normal-vs-Age(61-80Yrs) |
2.26539999998998E-05 |
| Normal-vs-Age(81-100Yrs) |
1.214050E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.706600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.787800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.048800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.023800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.700800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.587400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.009970E-02 |
| Classical-VS-Follicular |
3.524400E-02 |
| Classical-VS-Other |
1.171590E-01 |
| Classical-VS-Normal |
9.302200E-03 |
| Tall-VS-Follicular |
4.643000E-01 |
| Tall-VS-Other |
5.069800E-01 |
| Tall-VS-Normal |
6.21760000000249E-05 |
| Follicular-VS-Other |
3.784600E-01 |
| Follicular-VS-Normal |
1.204840E-04 |
| Other-VS-Normal |
4.319300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.755000E-04 |
| Normal-vs-N1 |
7.036300E-04 |
| N0-vs-N1 |
4.991800E-01 |
|
|
